Canbi Pharma Tech Limited
1513883-39-0 Deuterated Ruxolitinib

1513883-39-0 Deuterated Ruxolitinib

Product name: Deuterated Ruxolitinib
CAS:1513883-39-0
MF:C17H18N6
MW:306.37
EINECS:
MDL No.:

Send Inquiry
Description

Properties
Appearance White to off-white powder

 

Application:

     The main use of Deuruxolitinib is to treat alopecia areata. As a JAK1 and JAK2 kinase inhibitor, Deuruxolitinib effectively blocks the inflammatory process driven by JAK by targeting the JAK-STAT signaling pathway, thereby managing alopecia areata, a challenging autoimmune disease
 

Synonyms:

Deuruxolitinib

CTP-543

(3R)-3-(2,2,3,3,4,4,5,5-octadeuteriocyclopentyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile

1H-PYRAZOLE-1-PROPANENITRILE, .BETA.-(CYCLOPENTYL-2,2,3,3,4,4,5,5-D8)-4-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)-, (.BETA.R)-

1513883-39-0

Deuruxolitinib-d8

(3R)-3-(2,2,3,3,4,4,5,5-D8)cyclopentyl-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1Hpyrazol-1-yl)propanenitrile

 

Hot Tags: 1513883-39-0 deuterated ruxolitinib, China 1513883-39-0 deuterated ruxolitinib manufacturers, suppliers, api xml format, api saml integration, Vitamin D2, api data access, Olivetol, api shipping api integration

Inquiry
goTop

(0/10)

clearall